Clinical Trials in Mesa, Arizona

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT ID: NCT04546399

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

NCT ID: NCT05039840

This clinical trial is studying a new treatment called Frexalimab (SAR441344) for adults aged 18 to 70 who have an active condition known as Systemic Lupus Erythematosus (SLE). The trial will compa...

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NCT ID: NCT06172296

This clinical trial is studying a new treatment approach for children with high-risk neuroblastoma, a type of cancer that affects nerve cells. The researchers want to find out if combining a medici...

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT ID: NCT06858878

This clinical trial is exploring a new medication called maridebart cafraglutide to see how effective it is for adults with type 2 diabetes who are also overweight or have obesity. The main goal is...

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

NCT ID: NCT05026866

The TRAILBLAZER-ALZ 3 study is a clinical trial focused on testing the safety and effectiveness of a drug called donanemab in people who have early signs of Alzheimer's disease but do not yet have ...

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

NCT ID: NCT06653153

The TRAILRUNNER-ALZ 3 study is looking at a new drug called Remternetug (LY3372993) to see if it can help people with early Alzheimer's disease. The main goal of the trial is to find out if this dr...

A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

NCT ID: NCT06859294

This clinical trial is studying a new medication called LY3541860 to see how it helps adults with moderately to severely active rheumatoid arthritis (RA) who have not responded well to at least one...

Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)

NCT ID: NCT05245695

The EndoCheck clinical trial is studying a new way to help diagnose endometriosis, a condition that can cause chronic pelvic pain in women. Researchers are testing a special computer program, calle...

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease

NCT ID: NCT05312879

This clinical trial is studying a new treatment called VX-147 for patients with a specific type of kidney disease known as APOL1-mediated proteinuric kidney disease. This condition can lead to prot...

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

NCT ID: NCT06411249

This clinical trial is studying the effectiveness and safety of a medication called belimumab in adults who have been diagnosed with early systemic lupus erythematosus (SLE) and are still experienc...

A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis

NCT ID: NCT04883619

This clinical trial is investigating a new treatment called nipocalimab for adults who have active Lupus Nephritis, a condition where the immune system causes inflammation in the kidneys. The main ...

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

NCT ID: NCT05702034

The LIBREXIA-STROKE trial is studying a new medication called milvexian to see if it can help prevent another ischemic stroke in people who have recently experienced one or a high-risk transient is...

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis

NCT ID: NCT06807424

This clinical trial is studying a new medication called icotrokinra to see how well it works and how safe it is for people with active psoriatic arthritis (PsA) who have already tried other biologi...

A Study to Learn How Well Mirena Works as Compared to Oral Progestin in Nonatypical Endometrial Hyperplasia in Women Who Have Started Their Periods

NCT ID: NCT06904274

This clinical trial is studying how well a device called Mirena works in treating women with a condition known as nonatypical endometrial hyperplasia (NAEH), which is when the lining of the uterus ...

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

NCT ID: NCT03871257

This clinical trial is looking at a new drug called selumetinib to see if it works as well or better than the standard treatments, carboplatin and vincristine, for children and young adults with lo...

Study of Zifibancimig in Participants With Neovascular Age-Related Macular Degeneration

NCT ID: NCT04567303

This clinical trial is studying a new treatment called zifibancimig for people with neovascular age-related macular degeneration (nAMD), a condition that affects vision. The trial aims to evaluate ...

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

NCT ID: NCT06629779

This clinical trial is studying a new drug called PF-06821497 (also known as Mevrometostat) to see if it works better when combined with another medication called enzalutamide for men with metastat...

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

NCT ID: NCT06864026

The TOGETHER AMPLIFY-PsA clinical trial is studying how effective the medication tirzepatide is when added to ixekizumab treatment for people with active psoriatic arthritis (PsA) who are also over...

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

NCT ID: NCT06312020

This clinical trial is investigating a new treatment called HZN-1116 for people with Sjogren's syndrome, a condition that affects moisture-producing glands and can cause dry mouth and eyes, among o...